We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of ALBO yet.

ALBO Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q1 2026, worth a combined $44 — unchanged from a quarter earlier.

Fund positioning in ALBO was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Albireo Pharma Inc (ALBO) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $44 of Albireo Pharma Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Albireo Pharma Inc positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.